A combination of two drugs and a lifestyle intervention will be tested to prevent dementia.

29/12/2025

A clinical trial led by a team from the Hospital del Mar Research Institute, in collaboration with Hospital de la Santa Creu i Sant Pau, has received nearly €1.3 million in funding from Spain's Carlos III Health Institute (ISCIII), under the 2025 call of the Strategic Action in Health-Strategic Lines of Health Research. It is one of the 14 clinical trials selected. The trial is led by Dr. Ana Aldea, coordinator of the HMRIB Clinical Research Unit and Head of the Clinical Pharmacology Section at Hospital del Mar, and Dr. Rafael de la Torre, coordinator of the Integrated Pharmacology and Systems Neuroscience Research Group at the Hospital del Mar Research Institute.

Read more sobre "A combination of two drugs and a lifestyle intervention will be tested to prevent dementia."